Protein Stability Analysis Market

Global Protein Stability Analysis Market Size (2023 to 2028)

The global market for protein stability analysis is predicted to grow from USD 1.79 billion in 2023 to USD 2.78 billion in 2028, growing at a CAGR of 9.22% from 2023 to 2028.

Protein stability analysis is performed in research laboratories and pharmaceutical companies. These techniques estimate the quality and effectiveness of drug products under various environmental conditions. Protein stability is balanced overall, determining whether a protein will be in its native folded conformation or a denatured state. Protein stability awareness is important for optimizing the formulation, storage, expression, purification, and structure of proteins, along with its effective application in the market. Protein stability also helps with drug outflow in a person's body, which is important for drug effectiveness and accurate interaction. 

Impact of COVID-19 on the global protein stability analysis market:

A shutdown of various industries has affected the global supply chains and negatively impacted the manufacturing and sales of products worldwide. The Biopharmaceuticals firms are at the front position of the individual reaction to the Covid-19 pandemic. Due to the COVID-19 pandemic, there is a growing demand for protein analysis for synthetic vaccines, peptidomimetic antagonists, and therapeutic drugs. In analyzing such conditions and gaining an insight into bio information, KRSFIEDLLFNKV of the S2′ spike glycoprotein proteolytic cleavage site plays an integral role. R&D labs also focus on finding an advanced vaccine against Novel coronavirus, whereas protein studies are mainly focused on. The COVID-19 outbreak further boosted the continuous accentuation of research activities for developing new drugs. Compounds such as emodin, which prevents SARS entry, apparently by ACE2 binding, also have an essential role. 

MARKET DRIVERS:

The growth of the global protein stability analysis market is primarily driven by the increasing pharmaceutical outsourcing, increasing employment in the drug development industry, development of high throughput techniques, and increasing adoption of innovation models in biotechnology companies.

Additionally, increasing government funding and participation of research institutes to discover new therapies are driving market growth. The increase in contract research service providers has made protein characterization more efficient and affordable. Therapeutic proteins are produced by recombinant DNA technology, including interferons, thrombolytic drugs, interleukins, recombinant hormones, tumor necrosis factors, blood-clotting factors, enzymes, monoclonal antibodies, vaccines, and many others. These proteins are mainly responsible for most severe diseases. As a result, Protein stability analysis is becoming substantially more necessary.

A rise in healthcare spending, investment, technical advancements, and increasing infrastructure of healthcare facilities are further boosting the protein stability analysis market. In addition, increasing investment in R&D and high-speed DNA sequencing combined with hereditary assortment in the grouping are favoring the market's growth rate. Furthermore, increased funding from the government in life sciences and research and expanding drug discovery by pharmaceutical companies are anticipated to support the market growth during the forecast period.

Protein kinase C plays a vital role in the early start of Alzheimer's and its progression in its starting stages. The rise in the number of Alzheimer's patients and assurance of some drugs to effectively reduce the effect on patients is expected to result in significant growth for the global protein stability market shortly.

MARKET RESTRAINTS:

The high cost of the analysis instruments and the lack of skilled professionals are the major restraints of the protein stability analysis market. In addition, the amount of time spent and investments for these studies and the impact on pharmaceutical and biotech organizations due to the ongoing COVID-19 pandemic are challenging factors for the protein stability analysis market.

REPORT COVERAGE:

This research report has segmented the global protein stability analysis market based on the product, technique, end-user, and region.

Protein Stability Analysis Market – By Product:

• Reagents and Assay Kits
• Instruments
• Consumables and Accessories
• Software

Based on the product, the reagents and assay kits segment dominated the protein stability analysis market in 2022. This is due to the more use of these products and the cost-effectiveness associated with them compared to other products. In addition, integrating reagents with software that helps conduct effective, fast, and cost-effective throughput screening of protein's thermal stability also contributes to the market share occupied by this segment.  

Protein Stability Analysis Market – By Technique:

• Chromatography
• Spectroscopy
• Surface Plasmon Resonance
• Differential Scanning Calorimetry

Based on the technique, the chromatography segment had the most significant global protein stability analysis market share in 2022 and is projected to grow at the highest CAGR of 11% during the forecast period. Chromatography is an important technique that permits the identification and purification of the components of a mixture regarding descriptive and analytical analyses. Moreover, chromatography is one of the most accurate techniques for the isolation and purification of proteins. Hence Various companies are focusing on commercializing new products based on this technology. 

Protein Stability Analysis Market – By End-User:

• Pharmaceutical and Biotechnological Companies
• Contract Research Organizations
• Academic and Government Institutes

The pharmaceutical and biotechnological companies segment accounted for the highest share of the global market in 2022 based on the end-user due to the growing adoption of open innovation models in pharmaceutical & biotechnology companies and increasing pharmaceutical outsourcing. 

Protein Stability Analysis Market – By Region:

• North America
• Asia pacific
• Europe
• Latin America
• Middle East & Africa

Geographically, North America dominated the protein stability analysis market worldwide in 2022. Public and private entities and funding programs initiate by the proteomics market are the factors driving the market forward in this region. In addition, the United States and Canada have a well-structured healthcare system that promotes R&D and drug discovery efforts, thereby enabling protein stability analysis market growth.

Followed by North America, the Asia Pacific is expected to have the highest global market share during the forecast period. Furthermore, the availability of raw materials, rising trends of outsourcing, and 3D printing are expected to drive significant growth in the protein stability analysis market. The pharmaceutical sector has tremendous growth. The segment has grown exponentially from $ 100 billion in 2017 to $ 1.3 trillion and is expected to reach $ 1.7 trillion by 2024. Alone, India accounts for over 3000 drug companies and 10500 manufacturing units, and China accounts for 3 to 6 thousand domestic pharmaceutical manufacturers. These statistics suggest the immense opportunity for Protein Stability in the pharmaceutical industry. Factors such as the growing number of clinical trials and the development of emerging economies like India and China would create lucrative opportunities for the Protein Stability Analysis market across the Asia-Pacific region.

Europe has moderate growth shortly due to the large population of senior population as well, and rising concerns about diseases like Alzheimer's are expected to fuel growth for the protein stability market in the region.

TOP COMPANIES IN THIS MARKET:

Cyanotech Corporation, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Chr. Hansen Holding A/S, DIC Lifetec Co., Ltd., Sensient Technologies Corporation., DDW The Colour House, Naturex S.A., and Prolgae Spirulina Supplies Pvt. Ltd are a few prominent players operating in the global protein stability analysis market profiled in this report.

RECENT MARKET DEVELOPMENTS:

• In 2019, Thermo Fisher Scientific and Genovis, a provider of enzyme products for biological drug development, announced that the companies had entered a collaborative research project to develop end-to-end procedures for creating complex and innovative biotherapeutics and their identification and monitoring.
• In 2021, Agilent Technologies Inc. announced a definitive agreement to acquire Resolution Bioscience Inc., a leader in developing and commercializing next-generation sequencing (NGS)-based precision oncology solutions.